Methylenetetrahydrofolate reductase (MTH-FR; EC 1.5.1.20) catalyzes the conversion of 5, 10-methylenetetrahydrofolate to 5-methyltetrahydrofolate, a cosubstrate for homocysteine remethylation to methionine. The human MTHFR gene (MIM *607093) has been localized at chromosome 1p36.3 (1) , and is composed of 11 exons (2) .
Twelve alleles of human MTHRF gene (0001-0012) have been identified so far (3) . MTHFR thermolabile polymorphisms (MTHFR, 677C-T, ALA222VAL and MTH-FR, 1298A-C, GLU429ALA) were investigated in several diseases. The mutation in the heterozygous or homozygous state correlated with reduced enzyme activity and increased thermolability in lymphocyte extracts; in vitro expression of the mutagenized cDNA containing the mutation confirmed its effect on the thermolability of MTHFR. Individuals homozygous for the mutation had significantly elevated plasma homocysteine levels. Thus, the 677C-T mutation may represent an important genetic risk factor for vascular disease (4-6). There are many articles connecting MTHFR mutations, mostly MTHFR 677C-T, with plasma homocysteine levels. Several meta-analyses showed a positive association of MTHFR mutations with vascular diseases (7) (8) (9) , although several did not (10-12).
Since both mutations (677C-T and 1298A-C MTHFR), when homozygous, were associated with a decreased DNA methylation status (although the effect was slightly less pronounced for the 1298A-C transversion), it was suggested that 1298CC MTHFR genotype, independently of folate availability, and 677TT MTHFR genotype with concomitant low folate levels, might be potential risk factors for diseases associated with decreased DNA methylation status (13) .
We believe that MTHFR mutations influence the homocysteine metabolism, but are in weak association with vascular diseases and could be analyzed in combination with other candidate genes for vascular diseases. There are no data on MTHFR-677 and MTHFR-1298 polymorphisms in Macedonian population and their possible associations with different diseases. The aim of this study was to analyze the association of methylenetetrahydrofolate reductase polymorphisms (MTHFR-677 and MTHFR-1298) with occlusive artery disease and deep venous thrombosis in order to investigate the role of MTHFR mutations as candidate genes in different vascular diseases in Macedonians.
Participants and methods

Participants
The total studied sample consisted of 226 participants, divided into three different groups as follows: healthy individuals, patients with occlusive artery disease, and patients with deep venous thrombosis.
Healthy individuals (n = 83). There were 40 women and 43 men, aged 40.7 ± 11.3 years, born in different parts of Macedonia. They were age and sex non-matched healthy individuals who attended the Institute for Transfusion for blood donation between May 5, 2003 and April 25, 2004 and agreed to take part in this study as a control group if a medical doctor declared their health as acceptable (on the basis of medical documentation, an interview, and physical examination). Individuals with family history of blood vessel diseases were excluded from the investigation.
Occlusive artery disease (n = 76). There were 29 women and 47 men with diagnosed and documented myocardial infarction (n = 52), brain infarction (n = 22), and peripheral artery thrombosis (n = 2). They were 63.3 ± 9.6 years old consecutive patients hospitalized at the Institute of Heart Diseases, University School of Medicine, or attended the Institute for Trans-fusion for outpatient treatment between May 5, 2003 and April 25, 2004 .
Deep venous thrombosis (n = 67). There were 45 women and 22 men with a diagnosis of deep venous thrombosis made by ultrasonography and/or venography. They were 57.7 ± 11.8 years old consecutive patients who attended the Institute of Heart Diseases, University School of Medicine and the Institute for Transfusion for outpatient treatment between May 5, 2003 and April 25, 2004 .
All individuals were of Macedonian origin and residents of different geographical areas of the Republic of Macedonia. All patients and healthy individuals included in this study signed a written consent to participate in the study, which was approved by the Ethics Committee of the Ministry of Education and Science of the Republic of Macedonia (No.
13-1672/4-02).
Genomic DNA isolation and storage DNA was isolated from peripheral blood leukocytes by phenol-chlorophorm extraction method or with BioRobot EZ1 workstation (QIAGEN) (14) . The quality and quantity of DNA was analyzed by GeneQuant (Pharmacia Biotech, Uppsala, Sweden). Isolated DNA samples were stored in the Macedonian Human DNA Bank (15) .
Typing methods
Assay for the identification of MTHFR mutations was based on polymerase chain reaction (PCR) and reverse-hybridization with CVD StripAssay (ViennaLab Labordiagnostika GmbH, Vienna, Austria). The procedure included three steps as follows: 1) DNA isolation; 2) PCR amplification using biotinylated primers; 3) hybridization of amplification products to a test strip containing allele-specific oligonucleotide probes immobilized as an array of parallel lines. Bound biotinylated sequences were detected using streptavidin-alkaline phosphatase and color substrates (16) . The assay covered 2 mutations -MTH-FR C677T and MTHFR A1298C. The genotype of the sample was determined using the enclosed Collector sheet or StripAssay Evaluator software, version 2.0 (ViennaLab Diagnostics GmbH).
Statistical analysis
The population genetics analysis package, PyPop, developed by the Biostatistics Core for the Workshop (17) (18) (19) , was used for analysis of the MTHFR data. Allele frequencies and expected Hardy Weinberg proportions (HWP) for each MTHFR mutation were determined (20). The exact test for genotype frequency deviation from HWP was performed, using the Arlequin implementation accessed via PyPop (21) . The single nucleotide polymorphisms that deviated from HWP were evaluated to determine whether there was an excess of homozygotes or heterozygotes. χ 2 test was used to determine if any particular genotypes were significantly different from the expected frequencies. The Ewens-Watterson homozygosity test of neutrality (22) with Slatkin's exact P values (23, 24) was used to indicate deviations from the hypothesis of neutral selection for each locus. Linkage disequilibrium was calculated, where D' weights the contribution to linkage disequilibrium of specific allele pairs by the product of their allele frequencies; W n is a re-expression of the χ 2 statistic for deviations between the observed and expected haplotype frequencies; and S is defined as twice the difference between log-likelihood of obtaining the observed data given the inferred haplotype frequencies [ln(L_1)], and the likelihood of the data under the null hypothesis of linkage equilibrium [ln(L_0)]) (25) . Pearson P values, crude odds ratio (OR), and Wald's 95% confidence interval (CI) were calculated to test the associations between MTHFR mutations and blood vessel disease with GraphPad Quick-Calcs -free statistical calculators (http://www. graphpad.com/quickcalcs/). The level of statistical significance was set at P<0.05.
Results
MTHFR alleles
Frequencies of MTHFR alleles, test of neutrality with F nd statistic (Ewens-Watterson test of neutrality), and Slatkin's Exact P Value with P of F statistics in Macedonians are shown in Table 1 .
The frequency of C alleles for MTHFR-677 varied between 0.575 for deep venous thrombosis, 0.612 for occlusive artery disease, and 0.645 for healthy participants, indicating a common wild type allele. The frequency of T allele was lower in healthy participants (0.355) than in patients with occlusive artery disease (0.388) or deep venous thrombosis (0.425). The frequency of A alleles for MTH-FR-1298 varied from 0.729 for healthy participants, 0.770 for patients with occlusive artery disease, and 0.746 for patients with deep venous thrombosis, indicating a common wild type allele. The frequency of C allele was 0.271 in healthy participants, 0.230 in patients with occlusive artery disease, and 0.254 in patients with deep venous thrombosis. For all the MTHFR alleles, the test of neutrality showed negative value for F nd statistics, without significant P of F statistics, which indicated balancing selection operating on the alleles at that locus in all the groups.
MTHFR genotypes
The most frequent MTHFR-677 genotype in healthy participants was CT, with the observed frequency of 44.6%. A lower frequency was found for CC (42.2%) and the lowest (13.2%) for TT. The frequencies of MTH-FR-677 CT and TT genotypes were slightly increased in patients with occlusive artery disease and deep venous thrombosis, with a decrease in CC genotype ( Table 2 ). All genotypes in healthy participants and patients with blood vessel disease showed no deviation from HWP. The most frequent MTHFR-1298 genotype in healthy participants was AA (49.4%). A lower frequency was found for CA genotype (47.0%) and the lowest for CC (3.6%). The frequency of MTHFR-1298 genotypes AA and CC was slightly increased in patients with occlusive artery disease and deep venous thrombosis, with a consecutive decrease in CA genotype. In some instances, χ 2 test could not be performed because the expected frequency (Table 2) .
MTHFR haplotypes and linkage disequilibrium
The most frequent haplotype of MTHFR-677:MTHFR-1298 in healthy Macedonians was CA, followed by TA, CC, and TC ( Table 5 ).
Association between MTHFR mutations and blood vessels diseases
We did not find a significant association between MTHFR-677 and MTHFR-1298 alleles or genotypes and occlusive artery disease (Pearson P>0.05; Table 6 ). There was also no Table 6 ).
We did not find a significant association between MTHFR haplotypes with occlusive artery disease (Pearson P>0.05; Table 7 ). We found a significant negative association between MTHFR/CA:CC diplotype and artery occlusive disease (P = 0.048; OR, 0.461; CI, 0.212-1.003). The rest of MTHFR diplotypes were not significantly associated with occlusive artery disease. We did not find a significant association between MTHFR haplotypes or diplotypes with deep venous thrombosis (Pearson P>0.05; Table 7 ).
Discussion
Our study confirmed the presence of MTH-FR-677, and MTHFR-1298 polymorphisms in Macedonian population, and their possible association with occlusive artery disease and deep venous thrombosis. There was no significant association of MTHFR-677 and MTH-FR-1298 polymorphisms with occlusive artery disease or deep venous thrombosis, except the protective effect of MTHFR/CA:CC diplotype against occlusive artery disease.
We found negative F nd for MTHFR-677 and MTHFR-1298, but no significant P of F value, which indicates that balancing selection is operating on the alleles at that cluster. In all groups MTHFR-677 and MTHFR-1298 did not deviate from HWP, while MTHFR-677: MTHFR-1298 haplotypes did. The same was true for MTHFR-677:MTHFR-1298 diplotypes in all groups (with few exclusions). We observed 6 of 10 possible diplotypes in all the groups. Four expected diplotypes (CC:TA, TC:TA, TC:CC, and TC:TC) were not found in any of the groups. We found a significant linkage disequilibrium between the pair of MTHFR-677:MTHFR-1298 loci in healthy population, occlusive artery disease, and deep venous thrombosis. The absence of diplo- types and significant linkage disequilibrium in Macedonians could be a result of selective pressures or low frequencies in the groups. High frequency of MTHFR-677/TT genotype (18-19%) was found in several studies conducted in Italy (4, (26) (27) (28) , while the lowest frequency (6.2%) was found in Germany (29) and Croatia (6%) (30) . The frequency of MTHFR-677/TT genotype in Greece was reported in 16.7% of the population (31) . Allele and genotype frequencies of MTHFR-677 in Macedonia were high compared with other European populations. Unfortunately, there are not enough data on the MTHFR-677 and MTHFR-1298 haplotypes and diplotypes to make reliable comparisons between populations, as well as association analysis with different diseases.
Geographic and ethnic distribution of the 677C-T polymorphism in the MTHFR gene was studied in more than 7000 newborns from 16 areas in Europe, Asia, the Americas, the Middle East, and Australia. The TT genotype was particularly common in northern China (20%), southern Italy (26%), and Mexico (32%). There was also some evidence for geographic gradients in Europe (north to south increase) and China (north to south decrease). The TT genotype frequency was low among newborns of African origin, medium among newborns of European origin, and high among newborns of American Hispanic origin. Areas with extreme frequencies showed deviations from HWP (Helsinki, southern Italy, and southern China). The findings suggested the existence of selective pressures leading to a marked variation (32) .
Several studies found a significant association of MTHFR-677 and/or MTHFR-1298 with blood vessel diseases, which is in discordance with our data (7) (8) (9) .
Non-significant association between MTHFR-677 and MTHFR-1298 alleles, genotypes, haplotypes, and diplotypes with occlusive artery disease and deep venous thrombosis found in our study is in agreement with most of the studies, especially on European populations (33) (34) (35) (36) (37) (38) (39) . Caucasian patients are the most convenient for examining disease associations due to their greater genotype variability and larger number of patients with coronary artery disease. Our results suggest that neither 677CT heterozygotes nor mutant homozygotes have an increased or decreased risk for coronary artery disease, compared with 677CC genotype. Likewise, 1793GA genotype did not demonstrate a significant association with coronary artery disease, compared with 1793GG patients (40).
A meta-analysis of the risk of coronary heart disease related to the 677C-T polymorphism showed that individuals with 677TT genotype have a significantly higher risk of coronary heart disease, particularly if they have a low folate status. These results supported the hypothesis that impaired folate metabolism, resulting in high homocysteine levels, is causally related to an increased risk of coronary heart disease (7-9). However, another meta-analysis, which included case-control and prospective studies, found no association of MTHFR 677 C→T polymorphism and coronary heart disease in Europe, North America, or Australia (10). In another study, eight candidate gene variants were analyzed in 32 431 individuals, comprising mainly Chinese, Japanese, and Korean individuals. Of eight candidate genes, the following three were associated with ischemic stroke: angiotensin I converting enzyme insertion/deletion polymorphism in the Chinese and Japanese; C677T variant of 5,10-MTH-FR in the Chinese and Koreans; and apolipoprotein E gene in the Chinese and Japanese (11) . Cardiovascular system diseases are complex genetic traits, which include hundreds of associated candidate genes (41) . Our study of two mutations of a single gene (MTHFR-677 and MTHFR-1298) can function as a beginning of a complex investigation of candidate genes for cardiovascular diseases in Macedonians. There is a possibility that positive results might be spurious and negative results a consequence of low statistical power of our study. This could be due to the small sample size or methodological shortcomings, such as possible selection of an inappropriate control group. In order to have more precise conclusions for genetic background of cardiovascular diseases in Macedonians, it is necessary to investigate as many candidate genes as possible, in welldefined subgroups of phenotypes, and with a larger number of participants.
In summary, the association of MTH-FR-677, and MTHFR-1289 polymorphisms with occlusive artery disease and deep venous thrombosis in Macedonians was not found, except for the protective effect of MTHFR/ CA:CC diplotype on artery occlusive disease. The results can be used for population metaanalysis, as well as for association studies with different diseases. Lewis 
